Pyridostigmine alleviates cardiac dysfunction via improving mitochondrial cristae shape in a mouse model of metabolic syndrome
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 134, 119-132
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81770293, 81473203)
This publication has 44 references indexed in Scilit:
- Mitochondrial Cristae Shape Determines Respiratory Chain Supercomplexes Assembly and Respiratory EfficiencyCell, 2013
- Identification of the molecular basis of doxorubicin-induced cardiotoxicityNature Medicine, 2012
- Mitochondria in the diabetic heartCardiovascular Research, 2010
- Cardiac Autonomic Neuropathy in DiabetesDiabetes Care, 2010
- Cardiac Remodeling in ObesityPhysiological Reviews, 2008
- Role of Mitochondrial Dysfunction in Insulin ResistanceCirculation Research, 2008
- Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer’s diseaseMedical Hypotheses, 2007
- Structure of cristae in cardiac mitochondria of aged ratMechanisms of Ageing and Development, 2006
- Reactive oxygen species have a causal role in multiple forms of insulin resistanceNature, 2006
- Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failureAmerican Heart Journal, 2003